Comment on Suissa. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6-10.
Thomas NyströmJohan BodegardThomas NyströmMarcus ThuressonAnna NorhammarJan W ErikssonPublished in: Diabetes care (2018)
Keyphrases